Edition:
United Kingdom

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

5.08USD
17 Aug 2018
Change (% chg)

$-0.28 (-5.22%)
Prev Close
$5.36
Open
$5.36
Day's High
$5.55
Day's Low
$4.99
Volume
119,426
Avg. Vol
114,434
52-wk High
$50.50
52-wk Low
$3.43

Chart for

About

Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and... (more)

Overall

Beta: --
Market Cap(Mil.): $5.77
Shares Outstanding(Mil.): 9.34
Dividend: --
Yield (%): --

Financials

  INNT.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.90 -- --
ROI: -- 1.78 14.61
ROE: -- 3.28 16.33

BRIEF-Innovate Biopharma Files For Mixed Shelf Of Up To $175 Mln

* INNOVATE BIOPHARMACEUTICALS INC FILES FOR MIXED SHELF OF UP TO $175.0 MILLION - SEC FILING

15 Mar 2018

BRIEF-Innovate Appoints June Almenoff As COO, Chief Medical Officer

* INNOVATE BIOPHARMACEUTICALS APPOINTS JUNE ALMENOFF, M.D., PH.D. AS CHIEF OPERATING OFFICER AND CHIEF MEDICAL OFFICER Source text for Eikon: Further company coverage:

13 Mar 2018

Earnings vs. Estimates